Study of Irinotecan Liposome Injection in Patients With Advanced Breast Cance

NCT04728035 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Irinotecan Liposome Injection

Sponsor

CSPC Ouyi Pharmaceutical Co., Ltd.